Sanmina Responds to COVID-19 Crisis

As global communities work together to combat the COVID-19 pandemic, Sanmina is leveraging its deep manufacturing expertise and global footprint to produce essential products vital to the medical and communications industries.

Sanmina Responds to the COVID-19 Pandemic

Sanmina teams in North America, EMEA and Asia ramp up production of essential medical and communications products.

Essential Medical Products

Sanmina has been producing medical systems used in professional, primary care and personal use environments for over 25 years. During the COVID-19 pandemic, Sanmina medical teams have ramped production of essential products critical for the medical community, including highly-complex diagnostic, treatment, monitoring and research solutions.

Adhering to the highest quality standards and global regulatory requirements, Sanmina has 16 medical facilities worldwide that are ISO 13485 certified and 10 sites that are FDA registered. Our IT and quality management system is developed centrally, deployed globally and audited independently. The quality management system is 21CFR Part 820 and Part 11 compliant. Learn more.

Essential Communications Products

With decades of experience across a broad range of communication solutions, Sanmina is producing essential products that enable mission-critical communications during the COVID-19 pandemic. The sub-assemblies and systems it produces are used in first responder radios, 5G and 4G cellular networks, optical systems for network infrastructures and computing and storage systems for data centers. Learn more.

Protecting Our Employees

Sanmina’s priority is the health and safety of our employees and we take great pride in the essential work they are performing during this critical time. Our operations around the world abide by all of the protocols issued by local government and health officials and each site is working closely with local authorities as the COVID-19 pandemic evolves.

Recent Video

Loading...

Follow Us

Recent Videos

Newsletter

Share This